[ad_1]
The single-dose jab is currently being administered to healthcare workers as part of the country’s Phase 1 vaccination rollout.
FILE: Image: AFP.
JOHANNESBURG – The South African Health Products Regulatory Authority (SAHPRA) has licensed the commercial use of Johnson & Johnson COVID-19 vaccine.
SAHPRA registered the vaccine with conditions on Wednesday.
The single-dose jab is currently being administered to healthcare workers as part of the country’s Phase 1 vaccination rollout.
More than 263,000 healthcare workers have been vaccinated since the Sisonke vaccination study began on February 17.
The vaccine is 57% effective in preventing moderate to severe forms of the disease.
Addressing the nation earlier this week, President Cyril Ramaphosa said 11 million doses of the Johnson & Johnson vaccine had been secured for the country and that about 20 million more had been planned.
Download the Eyewitness News app on your iOS or Android device.
[ad_2]
